Abstract
Treatment of pediatric head and neck tumors requires a multimodal approach, with integration of surgical specialties, radiation therapy, pediatric oncology, and supportive care. For benign and low-grade tumors, local control with surgery is the treatment of choice, and conservative approaches that minimize disfiguration and protect function are the cornerstone of their management. However, high-grade malignancies require a more aggressive approach in order to guarantee complete local control; moreover, most pediatric cancer patients are considered to have micrometastatic disease at the time of diagnosis. For those reasons, chemotherapy is a key element in the management of pediatric head and neck malignancies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Widemann BC, Adamson PC. Fundamentals of cancer chemotherapy. In: Carroll WL, Finlay JL, editors. Cancer in children and adolescents. Boston: Jones and Bartlett; 2010. pp. 95–112.
Yu AL, Gilman AL, Ozkaynak MF, et al. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med. 2010;363:1324–34.
Pappo AS, Patel SR, Crowley J, et al. R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II sarcoma alliance for research through collaboration study. J Clin Oncol. 2011;29:4541–7.
Hodi FS, O’Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711–23.
Carpenter EL, Mosse YP. Targeting ALK in neuroblastoma-preclinical and clinical advancements. Nat Rev Clin Oncol. 2012;9:391–9.
Gild ML, Bullock M, Robinson BG, Clifton-Bligh R. Multikinase inhibitors: a new option for the treatment of thyroid cancer. Nat Rev Endocrinol. 2011;7:617–24.
Bollag G, Tsai J, Zhang J, et al. Vemurafenib: the first drug approved for BRAF-mutant cancer. Nat Rev Drug Discov. 2012;11:873–86.
Haidar C, Jeha S. Drug interactions in childhood cancer. Lancet Oncol. 2011;12:92–9.
Kremer LCM, Mulder RL, Oeffinger KC, et al. A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the international late effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer. 2013;60:543–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Rodriguez-Galindo, C. (2014). Chemotherapy. In: Rahbar, R., Rodriguez-Galindo, C., Meara, J., Smith, E., Perez-Atayde, A. (eds) Pediatric Head and Neck Tumors. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8755-5_3
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8755-5_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8754-8
Online ISBN: 978-1-4614-8755-5
eBook Packages: MedicineMedicine (R0)